Corban pharm acquired Martindale Pharma creating its position as a leading UK-based specialty pharmaceutical company providing value adding pharmaceutical products to over 80 countries around the world. Specialising in the fields of Opioid Addiction, Critical Care and Pain, Corban pharm UK is recognized as a key partner to the NHS and the private hospital sector with a vast range of quality products.
Corban pharm acquired DB Ashbourne, which became the UK subsidiary of the Group. Corban pharm UK started to market and supply its products directly including Morphine Sulfate prolonged release .
DB Ashbourne LTD establishes in the UK as a branded pharmaceutical business, commercial operations started in 2009 with the marketing and supply of a range of prescription only medicines to the UK market and generating significant savings for the National Health Service.
Corban pharm acquired Prographarm Laboratoire in France.
Corban PHARM UK - PART OF THE CORBAN PHARM GROUP
By joining forces with Martindale Pharma, Corban pharm reinforced its presence in the UK and the combined group now benefits from a broader geographical reach. This allows the Group to commercialise its products into many markets helping patients around the world get access to better medicines.
The consolidation of Martindale Pharm with Corban pharm UK has enabled stronger manufacturing capabilities to be developed including solid dose, injectables and oral liquids.